Exports of the domestic biohealth industry hit a record high last year due to soaring demand for biosimilars, COVID-19 diagnostic kits and medical devices. Exports in related sectors reached $16.2 billion last year, exceeding $15 billion for the first time. It is expected that strong performance will continue this year due to the release of new biosimilars and the export of Omicron diagnostic kits.

According to Ministry of Trade, Industry and Energy on the 3rd, domestic biohealth exports amounted to $16.2 billion last year, up 16.9% from $13.9 billion the previous year. It surpassed $10 billion for the first time in 2020, followed by $15 billion last year. In December last year, it showed an upward trend,